Torrent Pharmaceuticals L

TORNTPHARM NSE Healthcare Pharmaceuticals
Nifty 100 Nifty 200 Nifty 500 Nifty Next 50 LargeMid 250 F&O
₹4,965.50
+0.72%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Comfortable interest cover: operating profit covers interest about 11.8 times.
  • Return on equity is healthy at 27.4%.
  • Return on capital employed is healthy at 15.2%.
  • Net profit margin is strong at 15.3%.
  • Profit has compounded about 12% a year over five years.
  • Sales have compounded about 12% a year over five years.
  • Pays a dividend (yield about 0.78%).
  • Has paid a dividend in each of the last 5 years on record.
  • Promoters hold a majority stake (60.78%).

!Watch-points

  • Higher leverage: debt-to-equity of 1.79 is above 1.

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreSafe zone
3.47

In Altman’s original study, companies in this range showed a low incidence of financial distress.

Computed without the working-capital term (current-asset split not available for this stock).

Piotroski F-ScoreModerate
4 / 7

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 7 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap₹ 1.89L Cr
Current Price₹ 4,965.50
High / Low₹ 5,250.00 / 3,480.60
Stock P/E79.30842
Book Value₹ 248.00
Dividend Yield0%
ROCE15.20%
ROE27.40%
Face Value₹ 5.00
Debt to Equity1.79
PEG Ratio3.76
EV / EBITDA35.19
Industry PE35.25
P/B Ratio20.034132
EPS₹ 63.92
Debt₹ 15,026 Cr
PAT Margin15.29%
Cash PAT₹ 3,257 Cr
ICR11.84
Promoter Holding60.78%
FII Holding17.97%
DII Holding12.77%
Public Holding8.39%

Note on calculated ratios: where a value is not published in the source data, we compute it from the reported financials — Debt to Equity = total borrowings ÷ (equity capital + reserves); EV / EBITDA = (market cap + debt − cash) ÷ (operating profit + depreciation); PEG = P/E ÷ 3-year profit growth %. These may differ slightly from other sources that use different periods or TTM figures. Current Price, Market Cap and P/E reflect the live quote (cached 15 min).

Compounded Sales Growth
10 Years 8.00%
5 Years 12.00%
3 Years 13.00%
TTM 33.00%
Compounded Profit Growth
10 Years 2.00%
5 Years 12.00%
3 Years 22.00%
TTM 10.00%
Stock Price CAGR
10 Years 20.00%
5 Years 25.00%
3 Years 36.00%
1 Year 36.00%
Return on Equity
10 Years 22.00%
5 Years 24.00%
3 Years 26.00%
Last Year 27.00%
Educational data only. Not a recommendation to buy, sell or hold any security.